National Cancer Institute et al., 2026: NCI's own institutional timeline of its drug-screening program, stating that Congress created the CCNSC in 1955 with $5 million, that about 11,000 compounds had been screened by the late 1950s, and that 114,000 compounds were acquired and tested between 1955 and 1967.
In 1955, Congress established the Cancer Chemotherapy National Service Center (CCNSC) with $5 million in funding, primarily for cancer research grants and compound testing. By the late 1950s, after screening around 11,000 compounds, the CCNSC was recognized for encouraging new screening methods.
HTML page, unpaginated
National Cancer Institute et al., 2026: NCI's own institutional timeline of its drug-screening program, stating that Congress created the CCNSC in 1955 with $5 million, that about 11,000 compounds had been screened by the late 1950s, and that 114,000 compounds were acquired and tested between 1955 and 1967. Funder/conflicts: n/a (NCI self-history; institutional interest in emphasizing its role). Maker: n/a. Comparator: n/a. The same page carries NCI's list of 'FDA Approved Anticancer Treatments Developed with DTP Involvement' covering 1957-2018; I counted 56 named treatments/molecules across 33 dated rows (counting compounds, not entries). NCI gives no percentage on this page. Study type: other.
